Preparation of gelatin hydrogels incorporating small interfering RNA for the controlled release

Journal of Drug Targeting

Volumn 20, Issue 10, 2012, Pages 864-872

  Saito, Takashi ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

controlled release; Gelatin hydrogel; gene delivery; siRNA

Indexed keywords

CARBOXYL GROUP; COLLAGENASE; ETHYLENEDIAMINE; GELATIN; PHOSPHATE; PHOSPHATE BUFFERED SALINE; SMALL INTERFERING RNA;

ARTICLE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG SYNTHESIS; ENZYME DEGRADATION; GENE EXPRESSION; HYDROGEL; PRIORITY JOURNAL;

BASE SEQUENCE; GELATIN; HYDROGELS; RNA, SMALL INTERFERING;

EID: 84868369656     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.725170     Document Type: Article

References (33)

1. Andrieu-Soler C, Doat M, Halhal M, Keller N, Jonet L, BenEzra D, Behar-Cohen F. (2006). Enhanced oligonucleotide delivery to mouse retinal cells using iontophoresis. Mol Vis, 12, 1098-1107. (Pubitemid 44473664)
2. Doi N, Jo JI, Tabata Y. (2011). Preparation of biodegradable gelatin nanospheres with a narrow size distribution for carrier of cellular internalization of plasmid DNA. J Biomater Sci Polym Ed, 23, 991-1004.
3. Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2, 161-174. (Pubitemid 37328786)
4. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811. (Pubitemid 28099681)
5. Gilbert DF, Erdmann G, Zhang X, Fritzsche A, Demir K, Jaedicke A, Muehlenberg K, Wanker EE, Boutros M. (2011). A novel multiplex cell viability assay for high-throughput RNAi screening. PLoS ONE, 6, e28338.
6. Gong H, Liu CM, Liu DP, Liang CC. (2005). The role of small RNAs in human diseases: potential troublemaker and therapeutic tools. Med Res Rev, 25, 361-381. (Pubitemid 40489667)
7. Holland TA, Tessmar JK, Tabata Y, Mikos AG. (2004). Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release, 94, 101-114. (Pubitemid 37542381)
8. Jacobson GB, Gonzalez-Gonzalez E, Spitler R, Shinde R, Leake D, Kaspar RL, Contag CH, Zare RN. (2010). Biodegradable nanoparticles with sustained release of functional siRNA in skin. J Pharm Sci, 99, 4261-4266.
9. Jensen DK, Jensen LB, Koocheki S, Bengtson L, Cun D, Nielsen HM, Foged C. (2012). Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release, 157, 141-148.
10. Kim HJ, Ishii A, Miyata K, Lee Y, Wu S, Oba M, Nishiyama N, Kataoka K. (2010). Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown. J Control Release, 145, 141-148.
11. Kimura Y, Miyazaki N, Hayashi N, Otsuru S, Tamai K, Kaneda Y, Tabata Y. (2010). Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Tissue Eng Part A, 16, 1263-1270.
12. Kohara H, Tabata Y. (2011). Enhancement of ectopic osteoid formation following the dual release of bone morphogenetic protein 2 and Wnt1 inducible signaling pathway protein 1 from gelatin sponges. Biomaterials, 32, 5726-5732.
13. Krebs MD, Jeon O, Alsberg E. (2009). Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. J Am Chem Soc, 131, 9204-9206.
14. Kushibiki T, Matsumoto K, Nakamura T, Tabata Y. (2004). Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres. Pharm Res, 21, 1109-1118. (Pubitemid 38954194)
15. Le Pecq JB, Paoletti C. (1966). A new fluorometric method for RNA and DNA determination. Anal Biochem, 17, 100-107.
16. Lin X, Jo H, Ishii TM, Fujita M, Fu M, Tambara K, Yamamoto M, Tabata Y, Komeda M, Matsuoka S. (2009). Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats. Circ J, 73, 2315-2321.
17. Lobovkina T, Jacobson GB, Gonzalez-Gonzalez E, Hickerson RP, Leake D, Kaspar RL, Contag CH, Zare RN. (2011). In vivo sustained release of siRNA from solid lipid nanoparticles. ACS Nano, 5, 9977-9983.
18. Marshall E. (2002). Gene therapy. What to do when clear success comes with an unclear risk? Science, 298, 510-511. (Pubitemid 35215282)
19. Matsumoto G, Kushibiki T, Kinoshita Y, Lee U, Omi Y, Kubota E, Tabata Y. (2006). Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Sci, 97, 313-321.
20. Nagane K, Kitada M, Wakao S, Dezawa M, Tabata Y. (2009). Practical induction system for dopamine-producing cells from bone marrow stromal cells using spermine-pullulan-mediated reverse transfection method. Tissue Eng Part A, 15, 1655-1665.
21. Nelson CE, Gupta MK, Adolph EJ, Shannon JM, Guelcher SA, Duvall CL. (2012). Sustained local delivery of siRNA from an injectable scaffold. Biomaterials, 33, 1154-1161.
22. Newman CM, Bettinger T. (2007). Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther, 14, 465-475. (Pubitemid 46390919)
23. Obata Y, Nishino T, Kushibiki T, Tomoshige R, Xia Z, Miyazaki M, Abe K, Koji T, Tabata Y, Kohno S. (2012). HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice. Acta Biomater, 8, 2688-2696.
24. Ratanavaraporn J, Furuya H, Kohara H, Tabata Y. (2011). Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials, 32, 2797-2811.
25. Reed SD, Li S. (2009). Electroporation advances in large animals. Curr Gene Ther, 9, 316-326.
26. Rye PD, Stigbrand T. (2004). Interfering with cancer: a brief outline of advances in RNA interference in oncology. Tumour Biol, 25, 329-336. (Pubitemid 40082339)
27. Saito T, Tabata Y. (2012). Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy. Acta Biomater, 8, 646-652.
28. Tabata Y, Nagano A, Ikada Y. (1999). Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng, 5, 127-138. (Pubitemid 29196555)
29. Tabata Y, Miyao M, Inamoto T, Ishii T, Hirano Y, Yamaoki Y, Ikada Y. (2000). De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. Tissue Eng, 6, 279-289. (Pubitemid 30419210)
30. Tanigo T, Takaoka R, Tabata Y. (2010). Sustained release of waterinsoluble simvastatin from biodegradable hydrogel augments bone regeneration. J Control Release, 143, 201-206.
31. Tuzmen S, Tuzmen P, Arora S, Mousses S, Azorsa D. (2011). RNAibased functional pharmacogenomics. Methods Mol Biol, 700, 271-290.
32. Xia H, Mao Q, Paulson HL, Davidson BL. (2002). siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol, 20, 1006-1010.
33. Zamore PD, Tuschl T, Sharp PA, Bartel DP. (2000). RNAi: doublestranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 101, 25-33.